Psoralen binds to NLRP3 and prevents its phosphorylation at Serine 658, effectively blocking NLRP3 inflammasome activation and neuroinflammation, thereby mitigating PD-like motor symptoms and neurodegeneration. Here, NLRP3 is linked to Parkinson disease.